Mirum Pharmaceuticals, Inc. (MIRM)
97.46
+1.95
(+2.04%)
USD |
NASDAQ |
Nov 20, 10:21
Mirum Pharmaceuticals Free Cash Flow : -308.85M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -308.85M |
| June 30, 2026 | -263.74M |
| March 31, 2026 | -182.55M |
| December 31, 2025 | 54.87M |
| September 30, 2025 | 44.32M |
| June 30, 2025 | -1.373M |
| March 31, 2025 | -27.87M |
| December 31, 2024 | -10.67M |
| September 30, 2024 | -27.20M |
| June 30, 2024 | -39.22M |
| March 31, 2024 | -42.04M |
| December 31, 2023 | -91.05M |
| September 30, 2023 | -103.95M |
| June 30, 2023 | -111.77M |
| Date | Value |
|---|---|
| March 31, 2023 | -114.56M |
| December 31, 2022 | -120.41M |
| September 30, 2022 | -138.05M |
| June 30, 2022 | -146.23M |
| March 31, 2022 | -166.24M |
| December 31, 2021 | -151.78M |
| September 30, 2021 | -135.94M |
| June 30, 2021 | -119.22M |
| March 31, 2021 | -96.06M |
| December 31, 2020 | -89.30M |
| September 30, 2020 | -66.76M |
| June 30, 2020 | -64.65M |
| March 31, 2020 | -55.62M |
| December 31, 2019 | -39.64M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Incyte Corp. | 679.87M |
| Galectin Therapeutics, Inc. | -14.61M |
| TG Therapeutics, Inc. | 85.56M |
| Ardelyx, Inc. | -15.96M |
| Kodiak Sciences, Inc. | -172.81M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.311M |
| Cash from Investing (Quarterly) | -28.87M |
| Cash from Financing (Quarterly) | -54.34M |
| Free Cash Flow Per Share (Quarterly) | -0.0857 |
| Free Cash Flow to Equity (Quarterly) | 13.77M |
| Free Cash Flow to Firm (Quarterly) | -3.988M |
| Free Cash Flow Yield | -4.86% |